LobbyingEdwards Lifesciences lobbying by quarter
Edwards Lifesciences EW's latest lobbying report covers Q2 2026, at $490K. The four quarters Q3 2025–Q2 2026 total $1.9M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Edwards LifesciencesEW
- Latest quarter
- $490K
- Q2 2026 · 5 reports
- Last 12 months
- $1.9M
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $510K | 4 |
| Q1 2023 | $590K | 4 |
| Q2 2023 | $530K | 4 |
| Q3 2023 | $490K | 4 |
| Q4 2023 | $540K | 4 |
| Q1 2024 | $600K | 4 |
| Q2 2024 | $570K | 4 |
| Q3 2024 | $520K | 4 |
| Q4 2024 | $570K | 4 |
| Q1 2025 | $500K | 4 |
| Q2 2025 | $510K | 4 |
| Q3 2025 | $430K | 4 |
| Q4 2025 | $500K | 4 |
| Q1 2026 | $490K | 4 |
| Q2 2026 | $490K | 5 |
Policy issues the reports name
- Health issues47 reports
- Medicare and Medicaid45 reports
- Trade15 reports
- Taxation12 reports
- Clean air and water8 reports
- Veterans4 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE59 reports
- HOUSE OF REPRESENTATIVES57 reports
- Health & Human Services, Dept of (HHS)32 reports
- Centers For Medicare and Medicaid Services (CMS)30 reports
- Food & Drug Administration (FDA)15 reports
- White House Office3 reports
- Commerce, Dept of (DOC)1 reports
- U.S. Trade Representative (USTR)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseEdwards Lifesciences | $5.4M | 15 quarters |
| Avenue Solutions | $850K | 15 quarters |
| BGR Government Affairs | $810K | 15 quarters |
| Farragut Partners | $750K | 15 quarters |
| Akin Gump Strauss Hauer & Feld | $60K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRENT ALAN DEL MONTE | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee | Q2 2026 |
| CHARLIE CHAPMAN | Policy Advisor, HHS; Special Asst, HHS; Prof Staff Member, House Budget Committee; LA, House Budget Committee; Staff Asst, House Ways and Means Committee; Intern, House Ways and Means Committee | Q2 2026 |
| CHRIS KELLY | Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn | Q2 2026 |
| CONSTANTINE HINGSON | Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole | Q2 2026 |
| DANIEL FARMER | Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space | Q2 2026 |
| DYLAN MOORE | Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10) | Q2 2026 |
| EDWARD WHITFIELD | U.S. Representative (21 yrs.) | Q2 2026 |
| JAMES WILLIAMS | Special Assist. to the Pres., WH Domestic Policy Council, 2019-2021; Economist, WH Council of Economic Advisors, 2017-2019 | Q2 2026 |
| JEFFERY C. MORTIER | Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes | Q2 2026 |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (R-Texas) | Q2 2026 |
| JOEL D. BAILEY | COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall | Q2 2026 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q2 2026 |
| KRISTEN BAUTZ | Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz | Q2 2026 |
| RAGHAV AGGARWAL | Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior | Q2 2026 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q2 2026 |
| ROBB WALTON | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes | Q2 2026 |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux | Q2 2026 |
| AMY TEJRAL | Legislative Director, Sen. Ben Nelson | Q1 2026 |
| MATTHEW FUENTES | LA - Senate Democratic Minority Leader Sen. Chuck Schumer; LA - Senate Democratic Majority Leader Sen. Chuck Schumer; Legislative Aide - Sen. Chuck Schumer; Research Assistant - Senate Finance Committee (Sen. Ron Wyden) | Q2 2025 |
| BRIAN LOOSER | Pol. Ad. (Sen. Bill Cassidy, LA) LD (Rep. John Shimkus, IL-15) Sr Policy Advisor (Sen. Mark Kirk, IL) LA (Rep. Judy Biggert, IL-13) Leg. Corr./LA (Rep. Michele Bachmann, MN-06) Staff Asst./Leg. Corr.(Rep. Dennis Hastert, IL-14) | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $280K |
| 07/20for Q2 | BGR Government Affairs | $50K |
| 07/20for Q2 | Avenue Solutions | $50K |
| 07/20for Q2 | Farragut Partners | $50K |
| 07/20for Q2 | Akin Gump Strauss Hauer & Feld | $60K |
| 06/29for Q2 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 04/20for Q1 | Avenue Solutions | $50K |
| 04/20for Q1 | In-house | $340K |
| 04/20for Q1 | BGR Government Affairs | $50K |
| 04/20for Q1 | Farragut Partners | $50K |
| 01/20for Q4 2025 | In-house | $350K |
| 01/20for Q4 2025 | Avenue Solutions | $50K |
| 01/20for Q4 2025 | Farragut Partners | $50K |
| 01/20for Q4 2025 | BGR Government Affairs | $50K |
| 25/10/20for Q3 2025 | Avenue Solutions | $50K |
| 25/10/20for Q3 2025 | In-house | $280K |
| 25/10/20for Q3 2025 | Farragut Partners | $50K |
| 25/10/20for Q3 2025 | BGR Government Affairs | $50K |
| 25/07/21for Q2 2025 | Avenue Solutions | $50K |
| 25/07/21for Q2 2025 | BGR Government Affairs | $50K |